Associated Papers
Global analysis of suppressor mutations that rescue human genetic defects.
Ünlü B et al.
Genome Medicine, 2023
37821946 (PubMed )
Supplement: 13073_2023_1232_MOESM3_ESM.xlsx › Data
Genetic modifiers of age-at-onset in polyglutamine diseases.
Chen Z et al.
Ageing Research Reviews, 2018
Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.
Kumar S et al.
Journal of Genetics, 2018
Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders.
Lee SM et al.
Plos One, 2016
27341347 (PubMed )
Supplement: pone.0157540.s005.xlsx › Table_S5
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.
Cooper DN et al.
Human Genetics, 2013
Age at onset in Huntington's disease: replication study on the association of HAP1.
Karadima G et al.
Parkinsonism & Related Disorders, 2012
Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients.
Tsai YC et al.
Bmc Medical Genetics, 2012
Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.
Taherzadeh-Fard E et al.
Neurogenetics, 2010
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease.
Metzger S et al.
Human Molecular Genetics, 2008
Select a paper to view details